Extensive hippocampal demyelination in multiple sclerosis

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 9, 2007, Pages 819-827

  Geurts, Jeroen J G ^a   Bö, Lars ^a,c   Roosendaal, Stefan D ^a   Hazes, Thierry ^a   Daniëls, Richard ^a   Barkhof, Frederik ^a   Witter, Menno P ^a,d   Huitinga, Inge ^b   Van Der Valk, Paul ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Cognitive decline; Demyelination; Hippocampus; Inflammation

Indexed keywords

MYELIN PROTEIN; PROTEOLIPID;

ADULT; AGED; ARTICLE; BRAIN TISSUE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CADAVER; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN SHEATH;

EID: 34548441088     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e3181461f54     Document Type: Article

References (68)

1. Rao SM. Neuropsychology of multiple sclerosis. Curr Opin Neurol 1995;8:216-20
2. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991;41:685-91
3. Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry 2003;74:443-46
4. Amato MP, Bartolozzi ML, Zipoli V, et al. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. Neurology 2004;63:89-93
5. Rao SM, Hammeke TA, McQuillen MP, et al. Memory disturbance in chronic progressive multiple sclerosis. Arch Neurol 1984;41:625-631
6. Klonoff H, Clark C, Oger J, et al. Neuropsychological performance in patients with mild multiple sclerosis. J Nerv Ment Dis 1991;179:127-31
7. Gaudino EA, Chiaravalloti ND, DeLuca J, et al. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Neuropsychiatry Neuropsychol Behav Neurol 2001;14:32-44
8. Drake MA, Carra A, Allegri RF, et al. Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis. Neurol India 2006;54:370-76
9. Squire LR, Stark CE, Clark RE. The medial temporal lobe. Annu Rev Neurosci 2004;27:279-306
10. Moscovitch M, Nadel L, Winocur G, et al. The cognitive neuroscience of remote episodic, semantic and spatial memory. Curr Opin Neurobiol 2006;16:179-90
11. Neumann PE, Mehler MF, Horoupian DS, et al. Atypical psychosis with disseminated subpial demyelination. Arch Neurol 1988;45:634-36
12. Fontaine B, Seilhean D, Tourbah A, et al. Dementia in two histologically confirmed cases of multiple sclerosis: One case with isolated dementia and one case associated with psychiatric symptoms. J Neurol Neurosurg Psychiatry 1994;57:353-59
13. Vercellino M, Plano F, Votta B, et al. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005;64:1101-7
14. Dawson JW. The histology of multiple sclerosis. Trans R Soc Edinburgh 1916;50:517-740
15. Brownell B, Hughes JT. The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315-20
16. Peterson JW, Bo L, Mork S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001;50:389-400
17. Bo L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-32
18. Bo L, Vedeler CA, Nyland H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003;9:323-31
19. Bo L, Geurts JJ, van der Valk P, et al. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Arch Neurol 2007;64:76-80
20. Brink BP, Veerhuis R, Breij EC, et al. The pathology of multiple sclerosis is location-dependent: No significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005;64:147-55
21. Geurts JJ, Bo L, Pouwels PJ, et al. Cortical lesions in multiple sclerosis: Combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572-77
22. Ge Y, Grossman RI, Udupa JK, et al. Magnetization transfer ratio histogram analysis of normal-appearing gray matter and normal-appearing white matter in multiple sclerosis. J Comput Assist Tomogr 2002;26:62-68
23. De Stefano N, Matthews PM, Filippi M, et al. Evidence of early cortical atrophy in MS: Relevance to white matter changes and disability. Neurology 2003;60:1157-62
24. Dalton CM, Chard DT, Davies GR, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004;127:1101-7
25. Rovaris M, Gallo A, Valsasina P, et al. Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: An in vivo study using diffusion tensor MRI. Neuroimage 2005;24:1139-46
26. Vrenken H, Geurts JJ, Knol DL, et al. Whole-brain T1 mapping in multiple sclerosis: Global changes of normal-appearing gray and white matter. Radiology 2006;240:811-20
27. Bakshi R, Benedict RH, Bermel RA, et al. Regional brain atrophy is associated with physical disability in multiple sclerosis: Semiquantitative magnetic resonance imaging and relationship to clinical findings. J Neuroimaging 2001;11:129-36
28. Benedict RH, Bakshi R, Simon JH, et al. Frontal cortex atrophy predicts cognitive impairment in multiple sclerosis. J Neuropsychiatry Clin Neurosci 2002;14:44-51
29. Zarei M, Chandran S, Compston A, et al. Cognitive presentation of multiple sclerosis: Evidence for a cortical variant. J Neurol Neurosurg Psychiatry 2003;74:872-77
30. Prinster A, Quarantelli M, Orefice G, et al. Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study. Neuroimage 2006;29:859-67
31. Sepulcre J, Sastre-Garriga J, Cercignani M, et al. Regional gray matter atrophy in early primary progressive multiple sclerosis: A voxel-based morphometry study. Arch Neurol 2006;63:1175-80
32. Huitinga I, De Groot CJ, van der Valk P, et al. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol 2001;60:1208-18
33. Huitinga I, Erkut ZA, van Beurden D, et al. Impaired hypothalamuspituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions. Ann Neurol 2004;55:37-45
34. Pagani E, Rocca MA, Gallo A, et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 2005;26:341-46
35. Paulesu E, Perani D, Fazio F, et al. Functional basis of memory impairment in multiple sclerosis: A [18F]FDG PET study. Neuroimage 1996;4:87-96
36. Blinkenberg M, Rune K, Jensen CV, et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000;54:558-64
37. Geurts JJ, Reuling IE, Vrenken H, et al. MR spectroscopic evidence for thalamic and hippocampal, but not cortical, damage in multiple sclerosis. Magn Reson Med 2006;55:478-83
38. Rachbauer D, Kronbichler M, Ropele S, et al. Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: An fMRI study. J Neurol Sci 2006;244:11-16
39. De Groot CJ, Bergers E, Kamphorst W, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124:1635-45
40. Bo L, Geurts JJ, Ravid R, et al. Magnetic resonance imaging as a tool to examine the neuropathology of multiple sclerosis. Neuropathol Appl Neurobiol 2004;30:106-17
41. Singh DNP, Cookson FB. Atlas of the Human Brain and Spinal Cord. London: Croom Helm, 1983
42. Arnold SE, Trojanowski JQ. Human fetal hippocampal development: I. Cytoarchitecture, myeloarchitecture, and neuronal morphologic features. J Comp Neurol 1996;367:274-92
43. Nakamura M, Araki M, Oguro K, et al. Differential distribution of 68 Kd and 200 Kd neurofilament proteins in the gerbil hippocampus and their early distributional changes following transient forebrain ischemia. Exp Brain Res 1992;89:31-39
44. Woodhams PL, Celio MR, Ulfig N, et al. Morphological and functional correlates of borders in the entorhinal cortex and hippocampus. Hippocampus 1993;3 Spec No:303-11
45. Aronica EM, Gorter JA, Grooms S, et al. Aurintricarboxylic acid prevents GLUR2 mRNA down-regulation and delayed neurodegeneration in hippocampal CA1 neurons of gerbil after global ischemia. Proc Natl Acad Sci USA 1998;95:7115-20
46. Blumcke I, Pauli E, Clusmann H, et al. A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol (Berl) 2007;113:235-44
47. Vogt C, Vogt O. Sitz und Wesen der Krankheiten im Lichte der topostischen Hirnforschung under der Variierens der Tiere. J Psychol Neurol 1937;47:237-57
48. Woodward WR, Nishi R, Meshul CK, et al. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J Neurosci 1992;12:142-52
49. Gomez-Pinilla F, Lee JW, Cotman CW. Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and fimbria-fornix transection. J Neurosci 1992;12:345-55
50. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000;6:67-70
51. Werner P, Pitt D, Raine CS. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage. Ann Neurol 2001;50:169-80
52. Matute C, Sanchez-Gomez MV, Martinez-Millan L, et al. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA 1997;94:8830-35
53. Geurts JJG, Wolswijk G, Bo L, et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. Brain 2003;126:1755-66
54. Matute C, Alberdi E, Domercq M, et al. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci 2001;24:224-30
55. Gorter JA, Van Vliet EA, Proper EA, et al. Glutamate transporters alterations in the reorganizing dentate gyrus are associated with progressive seizure activity in chronic epileptic rats. J Comp Neurol 2002;442:365-77
56. Gilmore CP, Bo L, Owens T, et al. Spinal cord gray matter demyelination in multiple sclerosis-a novel pattern of residual plaque morphology. Brain Pathol 2006;16:202-208
57. Tiberio M, Chard DT, Altmann DR, et al. Gray and white matter volume changes in early RRMS: A 2-year longitudinal study. Neurology 2005;64:1001-7
58. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-12
59. Kutzelnigg A, Lassmann H. Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits? J Neurol Sci 2006;245:123-26
60. Comi G, Filippi M, Martinelli V, et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis. J Neurol Sci 1995;132:222-27
61. Rovaris M, Filippi M, Minicucci L, et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000;21:402-408
62. Benedict RH, Weinstock-Guttman B, Fishman I, et al. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004;61:226-30
63. Hildebrandt H, Hahn HK, Kraus JA, et al. Memory performance in multiple sclerosis patients correlates with central brain atrophy. Mult Scler 2006;12:428-36
64. Portaccio E, Amato MP, Bartolozzi ML, et al. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci 2006;245:195-99
65. Ranjeva JP, Audoin B, Au Duong MV, et al. Structural and functional surrogates of cognitive impairment at the very early stage of multiple sclerosis. J Neurol Sci 2006;245:161-67
66. Kidd D, Barkhof F, McConnell R, et al. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26
67. Geurts JJ, Pouwels PJ, Uitdehaag BM, et al. Intracortical lesions in multiple sclerosis: Improved detection with 3D double inversion-recovery MR imaging. Radiology 2005;236:254-60
68. Roosendaal SD, Geurts JJG, Moraal B, et al. MR imaging of hippocampal lesions in multiple sclerosis (Abstract). Mult Scler 2006;12:S174